American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1966)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (6)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1363)

Results (4048)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Putative biomarkers of clinical benefit with pembrolizumab in advanced urothelial cancer: Results from the KEYNOTE-045 and KEYNOTE-052 landmark trials
    Journal Article

    Bellmunt, J.; de Wit, R.; Fradet, Y.; Climent, M. A.; Petrylak, D. P.; Lee, J. L.; Fong, L.; Necchi, A.; Sternberg, C. N.; O'Donnell, P. H.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Natural history and characteristics of ERBB2-mutated hormone receptor-positive metastatic breast cancer: A multi-institutional retrospective case-control study from AACR Project GENIE
    Journal Article

    LeNoue-Newton, M. L.; Chen, S. C.; Stricker, T.; Hyman, D. M.; Blauvelt, N.; Bedard, P. L.; Meric-Bernstam, F.; Punglia, R. S.; Schrag, D.; Lepisto, E. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Capture rate of V(D)J sequencing for minimal residual disease detection in multiple myeloma
    Journal Article

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Jacob, A.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Smith, E. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tepotinib efficacy and safety in patients with MET exon 14 skipping NSCLC: Outcomes in patient subgroups from the VISION study with relevance for clinical practice
    Journal Article

    Le, X.; Sakai, H.; Felip, E.; Veillon, R.; Garassino, M. C.; Raskin, J.; Cortot, A. B.; Viteri, S.; Mazieres, J.; Smit, E. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Integrated analysis of ovarian juvenile granulosa cell tumors reveals distinct epigenetic signatures and recurrent TERT rearrangements
    Journal Article

    Vougiouklakis, T.; Zhu, K.; Vasudevaraja, V.; Serrano, J.; Shen, G.; Linn, R. L.; Feng, X.; Chiang, S.; Barroeta, J. E.; Thomas, K. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Telaglenastat plus cabozantinib or everolimus for advanced or metastatic renal cell carcinoma: An open-label phase I trial
    Journal Article

    Meric-Bernsta, F.; Tannir, N. M.; Iliopoulos, O.; Lee, R. J.; Telli, M. L.; Fan, A. C.; DeMichele, A.; Haas, N. B.; Patel, M. R.; Harding, J. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Radioimmunotherapy targeting Delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity
    Journal Article

    Tully, K. M.; Tendler, S.; Carter, L. M.; Sharma, S. K.; Samuels, Z. V.; Mandleywala, K.; Korsen, J. A.; Reyes, A. M. D.; Piersigilli, A.; Travis, W. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase Ib/II randomized study of RO4929097, a gamma-secretase or notch inhibitor with or without vismodegib, a hedgehog inhibitor, in advanced sarcoma
    Journal Article

    Gounder, M. M.; Rosenbaum, E.; Wu, N.; Dickson, M. A.; Sheikh, T. N.; D'Angelo, S. P.; Chi, P.; Keohan, M. L.; Erinjeri, J. P.; Antonescu, C. R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors
    Journal Article

    Demetri, G. D.; De Braud, F.; Drilon, A.; Siena, S.; Patel, M. R.; Cho, B. C.; Liu, S. V.; Ahn, M. J.; Chiu, C. H.; Lin, J. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: